Scientific Programme

Pre-Congress Symposium

Advisory Board meeting

Chairpersons: Alexander Haug, Michael Gabriel, Irene Burger, Clemens Decristoforo

Opening Lecture: KI in medical applications

Speaker: Henry Woodruff

Welcome Reception

Chairpersons: Wolfgang Wadsak, Elisabeth von Guggenberg

Speaker:

• Renata Mikolajczak: Which radionuclides do we need for theranostics
• Herbert Kvaternik: New Infrastructure in Austria - Graz
• Markus Mitterhauser: New Infrastructure in Austria - Vienna
• Clemens Decristoforo: New Infrastructure in Austria - Innsbruck

Chairpersons: Cecile Philippe, Marta Hoffmann

Speaker:

• Uta Eberlein: The importance of Radiobiology in RLT
• Mattias Sandström: Dosimetry in 1200 177Lu-DOTATATE patients: Experience and recent advances - a physicist's perspective

Oral Abstracts - Preclinical

• Jakob Pfeiffer-Vogl: Assessing the interaction of ciprofloxacin with membrane transporters by combined PET and in vitro transport studies
• Maximilian Anderla: Unlocking the Potential of Ruthenium Radioisotopes for Radiopharmaceutical Development
• Matthias Jackwerth: 6-Bromo-7-[11C]methylpurine as a novel PET tracer to assess cellular defense against oxidative stress in the human brain
• Emanuel Sporer: Establishment of Actinium-225 radiopharmaceutical production at the Medical University of Innsbruck

Chairpersons: Anton Hörmann, Rainer Lipp

Speaker:

• Elisabeth von Guggenberg: Update on the clinical translation of cholecystokinin-2 receptor targeted theranostics
• Constantin Lapa: FAP-targeting
• Serge Lyashchenko: Clinical Trials in the US- examples from MSKCC

Chairpersons: Markus Mitterhauser, Alexander Becherer

Speaker:

• Christos Sachpekidis: Whole body PET - does it change clinical management

Oral Abstracts - Mixed Rapid Fire: 

• Gregor Schweighofer-Zwink: Bridging the workforce gap? Current use and implementation barriers of AI in Austrian nuclear medicine
• Sven Messerschmidt: Optimization of the radiolabelling process for cholecystokinin-2 receptor targeting DOTA-MGS5 labelled with gallium-68 and lutetium-177
• Ramin Tahmasebi: External radiation exposure in 177Lu-based radioligand therapy
• Martin Kraihammer: Comparison of automated synthesis of radiopharmaceuticals for radioligand therapy with versus without C-18 purification
• Lukas Pichler: 18F-FDG PET/CT as a diagnostic landmark in a case of multifocal atypical primary bone lymphomas
• Petra Gröger: A novel approach for correcting the residual radiotracer activity concentration at the injection site
• Claas Duit: Quantification of Radiation Dose Reduction for Radiologic Technologists through the Use of Automated Injection Systems for FDG-PET in Austria

Chairpersons: Michael Gabriel

Speaker:

• Irene Virgolini + Team                          Pro
• Irene Burger + Team                              Con

Chairpersons: Hans-Jürgen Gallowitsch, Irene Virgolini

Speaker:

• Ursula Vogl: The oncologist's perspective
• Christian Pirich: How it's done in clinical practice
• Karolien Goffin: Novel approaches - is there room for improvement

Chairpersons: Hojjat Ahmadzadehfar, Christian Uprimny

Speaker:

• Wolfgang Schäfer: CZT for Cardiac SPECT - is quantification real
• Laszlo Papp: Marrying Nuclear Medicine and (Quantum) AI for advancing patient care

Oral Abstracts - Clinical

• Lisa-Maria Rossetti: Hybrid imaging with the innovative PET-tracer 68Ga-ABS011 in HER2-low metastatic breast and gynaecological cancer
• Holger Einspieler: [177Lu]Lu-PSMA-I&T radioligand therapy in hormone-sensitive prostate cancer with biochemical recurrence: interim clinical outcomes from a prospective trial
• Mohsen Beheshti: Baseline [18F]FDG PET/CT Predicts Response to Neoadjuvant Immunochemotherapy in HER2-Positive Early Breast Cancer: A Substudy of the ABCSG-52/ATHENE Trial
• Teresa Kiener: Can [68Ga]PSMA-PET/CT Guide Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer?

Chairpersons: Lukas Hehenwarter, Margret Schottelius

Speaker:

• Michael Kellner: Nuclear Medicine
• Elisabeth Plhak: Radiopharmacy
• Sabine Weissensteiner: NM Technologists
• Emanuel Sporer: Radiochemistry
• Flora Kaser: Medical Physics
• Margret Schottelius: EANM perspective

Chairpersons: Irene Burger, Clemens Decristoforo

Speaker:

• John Babich: The Evolution of Radiopharmaceuticals: From Radioiodine to Modern Radioligand Therapy 

at Kaiserliche Stallungen Bad Ischl

Chairperson: Georg Zettinig

Speaker:

• Lindsay Hargitai: Surgical treatment strategies for advanced differentiated thyroid cancer
• Markus Luster: Systemic therapy in advanced differentiated throid cancer
• Michael Gabriel: Theranostic approaches beyond I-131 in advanced differentiated thyroid cancer

Chairpersons: Oliver Langer, Robert Pichler, Tatjana Traub-Weidinger

Speaker:

• Johannes Sebastian Gnörich: PET Imaging of Dementia – a Tool for Patient Management Now and in the Future
• Tandis Parvizi: New anti-Alzheimer's drugs – Status Quo and Future Aspects – An Austrian Perspective

Chairpersons: Alexander Haug, Michael Gabriel, Irene Burger, Clemens Decristoforo